
Big Pharma’s Biggest Critic, Sanders, May Target Spending on FDA Drug Reviews
By HOLLIE McKAY
|Today’s default should be ‘conspiracy curious,’ as ‘conspiracy theorist’ sounds a lot like a synonym for responsible citizen — someone who is paying attention and has earned the right to question everything.

When a Danish drug maker, Novo Nordisk, announced recently that its weight loss drug, Wegovy, was demonstrated to reduce the risk of heart attacks and strokes by 20 percent, my first reaction was deep skepticism. It seemed quite the coincidence that just as news of damage to the heart in 2.5 percent of those taking MRNA shots was finally reaching the public, news of another big pharma product that improves the health of the exact same organ was released.

By HOLLIE McKAY
|
By JOSEPH CURL
|
By DAVID JONES
|
By GEORGE WILLIS
|
By JOSEPH CURL
|
By A.R. HOFFMAN
|
By DONALD KIRK
|
By A.R. HOFFMAN
|When a Danish drug maker, Novo Nordisk, announced recently that its weight loss drug, Wegovy, was demonstrated to reduce the risk of heart attacks and strokes by 20 percent, my first reaction was deep skepticism. It seemed quite the coincidence that just as news of damage to the heart in 2.5 percent of those taking MRNA shots was finally reaching the public, news of another big pharma product that improves the health of the exact same organ was released.
Already have a subscription? Sign in to continue reading
Cancel anytime
By continuing you agree to our Privacy Policy and Terms of Service.
Cancel anytime